The authors present an update of the situation in Switzerland and their recommended approach in terms of preventive strategies.
The number of options for approaching a diseased aortic valve is probably the largest existing in the field of surgery.
Atypical parkinsonian syndromes are characterised by a modest or nonexistent response to dopaminergic therapy and a poor prognosis, with selective neuronal loss in distinct brain regions that differ from those involved in of Parkinson’s disease.
A decade ago, the Swiss National Science Foundation instigated clinical trial units (CTUs) at the five university hospitals and St Gallen cantonal hospital, with the aim of improving the quality of Swiss academic clinical research projects.
Various scoring systems aim to assess the quality of organs donated for transplantation. How well such scoring systems reflect the practice in lung transplantation in Switzerland has never been studied.
Coercion rates differ between and within countries and sometimes between wards of the same hospital. Previous research found inconsistent characteristics of individuals who underwent coercive measures during psychiatric treatment.
There is no centralised database on workers’ exposures to plant protection products in Switzerland, nor a national register for their negative health effects. This makes it difficult to implement research or prevention campaigns.
An increase in age has a greater impact on the development of primary osteoarthritis than other risk factors. It is important to ascertain the factors that promote ageing of the cartilage with the aim to prevent or reduce cartilage dysfunction.
Cartilage hair hypoplasia is a rare autosomal recessive ribosomopathy related to a mutation in the ribonuclease mitochondrial RNA processing (RMRP) gene, which encodes the mitochondrial portion of the RNA processing endonuclease.
In Switzerland, new-born screening for cystic fibrosis was started in 2011. This allows early monitoring and treatment of preclinical disease, and a better understanding of the early disease pathogenesis.
The current burden of healthcare-associated infections (HAIs) in Switzerland is unknown. Prevalence surveys have a long tradition in the field of infection prevention and control for measuring both HAI and antimicrobial use.
In Switzerland, laboratories and physicians have been obliged to notify the Federal Office of Public Health of individual cases of hepatitis since 1988. This is the first comprehensive analysis of nationwide mandatory hepatitis C surveillance.
An international peer-reviewed medical journal, established in 1871 as “Correspondenz-Blatt für Schweizer Aerzte”.
Newsletter for advertisers
Swiss Medical WeeklyEMH Swiss Medical Publishers Ltd.Farnsburgerstrasse 8CH-4132 MuttenzTel. +41 (0)61 467 85 55Fax +41 (0)61 467 85 56e-mail: Editorial office
EMH MediaSchweizerische ÄrztezeitungSwiss Medical ForumPrimary and Hospital CareCardiovascular MedicineSwiss Archives of Neurology, Psychiatry and PsychotherapySynapseSwiss Medical Informatics